As of July 2025 MacroGenics has a market cap of โน8.68 Billion. This makes MacroGenics the world's 9278th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โน8.68 B | -50.09% |
2024 | โน17.39 B | -64.99% |
2023 | โน49.67 B | 45.53% |
2022 | โน34.13 B | -53.39% |
2021 | โน73.23 B | -22.11% |
2020 | โน94.03 B |
On Jul 29th, 2025 the market cap of MacroGenics was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Xencor XNCR | โน54.66 B | 529.72% | ๐บ๐ธ USA |
![]() Pfizer PFE | โน12.030 T | 138,494.26% | ๐บ๐ธ USA |
![]() Merck MRK | โน18.067 T | 208,046.89% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | โน12.373 T | 142,446.45% | ๐บ๐ธ USA |
![]() Amgen AMGN | โน14.213 T | 163,645.62% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | โน59.643 T | 687,008.01% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | โน8.304 T | 95,567.42% | ๐บ๐ธ USA |